Cite
HARVARD Citation
Wu, Y. et al. (2022). A systematic comparison of hepatobiliary adverse drug reactions in FDA and EMA drug labeling reveals discrepancies. Drug discovery today. 27 (1), pp. 337-346. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wu, Y. et al. (2022). A systematic comparison of hepatobiliary adverse drug reactions in FDA and EMA drug labeling reveals discrepancies. Drug discovery today. 27 (1), pp. 337-346. [Online].